PDEdelta

PF3D7_1470500 (PDEdelta) is a cyclic-nucleotide phosphodiesterase that governs transmission-stage biology in Plasmodium by keeping cyclic nucleotide levels below thresholds that trigger downstream signalling (PMID:18452584, PMID:19779564). In vitro it is a dual-specificity enzyme that hydrolyzes both cAMP and cGMP, with higher affinity for cAMP (PMID:36708871). During P. falciparum gametocyte development, PDEdelta is required to restrain cGMP so that gametogenesis can proceed normally; its disruption severely reduces gametogenesis (PMID:18452584). In mature gametocyte stages PfPDEdelta localizes to the parasitophorous vacuole at the host erythrocyte–parasite interface (PMID:36708871), and it acts as a master regulator of infected-erythrocyte mechanics, controlling increased erythrocyte deformability and inhibition of channel activity through the cAMP pathway (PMID:36708871). In P. berghei ookinetes, PDEdelta is the principal cGMP-degrading enzyme acting downstream of guanylyl cyclase beta: loss of PDEdelta causes unregulated cGMP signalling and rounding of the banana-shaped cell, a phenotype suppressed by additional deletion of GCbeta, and the same cGMP module regulates gliding motility with partial overlap with the CDPK3 calcium-dependent pathway upstream of PKG (PMID:19779564). No structural model, catalytic-residue mapping, or regulatory-partner biochemistry for PDEdelta has been characterized in the available corpus.

1. 2008 Medium

   Established that PDEdelta is functionally required during sexual-stage development, answering whether cyclic-nucleotide turnover gates gametocyte differentiation.

   Evidence Gene disruption in P. falciparum with gametogenesis phenotype readout

   PMID:18452584

   Open questions at the time

   • Substrate specificity not determined in this study
   • Subcellular site of action not defined
   • Downstream effector (PKG vs PKA) not identified
2. 2009 High

   Placed PDEdelta in a defined cGMP signalling module by identifying its cognate cyclase, resolving which enzymes generate and degrade the relevant cGMP pool in ookinetes.

   Evidence Genetic epistasis (PDEdelta × GCbeta double mutant) with ookinete morphology readout in P. berghei

   PMID:19779564

   Open questions at the time

   • Does not establish direct enzymatic contact between GCbeta and PDEdelta
   • cAMP contribution in ookinetes not addressed
   • Molecular link between cGMP level and cell shape not defined
3. 2009 Medium

   Connected the PDEdelta cGMP module to motility control and to calcium signalling, showing partial crosstalk between cGMP- and calcium-dependent pathways upstream of PKG.

   Evidence Genetic epistasis (PDEdelta knockout × CDPK3 mutant) with gliding motility assay in P. berghei

   PMID:19779564

   Open questions at the time

   • Mechanism of overlap between CDPK3 and cGMP pathways not defined
   • PKG involvement inferred, not directly tested here
   • Quantitative contribution of PDEdelta to motility not isolated from GCbeta
4. 2023 Medium

   Defined the biochemical activity of PDEdelta, resolving whether it is cGMP-specific or dual-specificity and thereby which second messengers it can control.

   Evidence In vitro phosphodiesterase assay with cAMP and cGMP substrates (P. falciparum enzyme)

   PMID:36708871

   Open questions at the time

   • Single lab, single study
   • Kinetic constants and physiological substrate preference in vivo not established
   • Regulation of catalytic activity not addressed
5. 2023 Low

   Assigned a cellular site and a host-cell phenotype to PDEdelta, showing it operates at the parasitophorous vacuole to control infected-erythrocyte mechanics via cAMP.

   Evidence Subcellular localization plus loss-of-function with deformability and channel-activity readouts in P. falciparum gametocyte-infected erythrocytes

   PMID:36708871

   Open questions at the time

   • Localization method not fully described and lacks rescue of a localization-disrupted mutant
   • Mechanistic link from cAMP to channel activity/deformability not resolved
   • Effector kinase (PKA) mediating the cAMP effect not identified

• How PDEdelta integrates its dual cAMP/cGMP activity across life-cycle stages and how its localization and catalytic activity are regulated remain unresolved.
• No structural model or catalytic-residue mapping
• No identified regulatory partners or complex members
• Stage-specific substrate preference (cAMP in gametocytes vs cGMP in ookinetes) not mechanistically reconciled